Skip to content

Clinical trials

Cardiovascular Diseases trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Not applicable Country / region: Canada Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20043
20063
20075
20084
20095
20106
20115
201212
20136
20148
20157
201610
20178
201816
201914
20209
20219
20226
20239
202410
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Unknown status30
Recruiting21
Active, not recruiting17
Not yet recruiting5
Terminated4
Withdrawn4
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laval University15
McMaster University12
University of British Columbia10
University of Manitoba10
University of Toronto10
Ottawa Heart Institute Research Corporation9
Unity Health Toronto6
University Health Network, Toronto6
Sunnybrook Health Sciences Centre5
Abbott Medical Devices4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases174
Diabetes Mellitus27
Heart Diseases23
Hypertension20
Stroke16
Heart Failure14
Metabolic Syndrome13
Obesity11
Hypercholesterolemia10
Central Nervous System Diseases8

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.